Optimization of piperazine-derived ureas privileged structures for effective antiadenovirus agents.
Mazzotta S, Marrugal-Lorenzo JA, Vega-Holm M, Serna-Gallego A, Álvarez-Vidal J, Berastegui-Cabrera J, Pérez Del Palacio J, Díaz C, Aiello F, Pachón J, Iglesias-Guerra F, Vega-Pérez JM, Sánchez-Céspedes J.
Mazzotta S, et al. Among authors: vega perez jm.
Eur J Med Chem. 2020 Jan 1;185:111840. doi: 10.1016/j.ejmech.2019.111840. Epub 2019 Nov 3.
Eur J Med Chem. 2020.
PMID: 31711794